News
The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner
-
Centenary researcher wins prestigious cardiac prize
Centenary Institute researcher and PhD candidate, Dr Julia Isbister, has been awarded the 2022 Ralph Reader Prize for Clinical Science by the Cardiac Society of Australia and New Zealand (CSANZ).News Type: Research NewsDate -
Award for outstanding COVID-19 research paper
A group of Australian researchers, including Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have won a Fukuchi (Respirology) Award for ‘outstanding original research paper’ published in the journal Respirology.News Type: Research NewsDate -
DPP9 enzyme role in cancer revealed
A new study from German and Centenary Institute researchers has provided new understanding of an enzyme called dipeptidyl peptidase 9 (DPP9) and its role in cancer development.News Type: Research NewsDate -
Professor Rasko features in the Sydney Morning Herald
Professor John Rasko AO, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute has featured in a Sydney Morning Herald (SMH) article on gene therapy and its growing emergence into the clinic.News Type: Media coverageDate -
What is the role of vascular endothelial cells?
Vascular endothelial cells serve as a protective barrier in blood vessel walls.News Type: DiscoverDate -
New drug target identified for inflammatory lung disease
Researchers at the Centenary Institute and the University of Technology Sydney have identified a new drug target for the treatment and prevention of chronic obstructive pulmonary disease (COPD), an inflammatory lung disease that causes airway blockage and that makes it difficult to breathe.News Type: Media releaseDate -
Inflammation presentation awarded
Dr Joyce Chiu from the ACRF Centenary Cancer Research Centre has won an Oral Communication Award for her talk given at the 15th World Congress on Inflammation, held in Rome, June 2022.News Type: Research NewsDate -
Meet Dr Annalicia Vaughan
A medical researcher at the Centenary UTS Centre for Inflammation, Dr Annalicia Vaughan specialises in the gut-lung axis and its role in lung and respiratory diseases.News Type: ProfilesDate -
The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner
The Centenary Institute welcomes the NSW Government’s commitment to fund a new biomedical complex in Camperdown. The Chair of the Centenary Institute Board, Joseph Carrozzi AM, and its Executive Director, Professor Mathew Vadas AO, are thrilled that a biomedical complex, the Sydney Biomedical Accelerator (SBA), will now be a reality.News Type: Media releaseDate -
Innovation Week – Getting to the heart of sudden death
Professor Chis Semsarian AM, Head of the Agnes Ginges Centre for Molecular Cardiology at the Centenary Institute and Cardiologist at the Royal Prince Alfred Hospital, has given a headline talk on the genetic basis of cardiovascular disease as a part of Sydney Local Health District’s 'Innovation Week' event.News Type: Research NewsDate -
2GB Healthy Living program interviews Dr Elinor Hortle
Dr Elinor Hortle, medical researcher at the Centenary Institute has been interviewed on Sydney radio 2GB’s Healthy Living program, discussing her latest findings on tackling mycobacterial infections. Responsible for diseases that include tuberculosis (TB), leprosy and serious skin ulcerations, mycobacterial infections cause significant harm and mortality to human health. Approximately 1.5 million people die each ...News Type: Media coverageDate -
World-first study reveals why people with COPD are more susceptible to COVID-19
Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19.News Type: Media releaseDate